Latest Announcements

Belrise Industries Limited has acquired the Tipper Body Business of Hyva (India) Pvt. Ltd. for approximately USD 5.65 million, strengthening its position as a Tier-0.5 supplier in the commercial vehicle ecosystem.

Belrise Industries Ltd has acquired the Tipper Body Business of Hyva India Private Ltd for approximately USD 5.65 million, with an EV/EBITDA multiple of 3.60x. The acquisition strengthens Belrise's position as a Tier-0.5 supplier in the commercial vehicle ecosystem and expands its capabilities in the commercial vehicle segment.

Belrise Industries Ltd has approved the acquisition of India Tipper body business of Hyva (India) Pvt. Ltd on slump sale basis for USD 5.65 million (approximately INR 543.88 million).

Urvashi Tilakdhar has acquired 20.65% stake in DCM Shriram Fine Chemicals Ltd, increasing her holding to 27.42%. The acquisition was made through an off-market transfer on August 1, 2026.

Jupiter Wagons Limited has formed a strategic partnership with Lucchini RS Holding S.p.A. to create India's first fully integrated private-sector railwheel manufacturing platform, backed by the Government of Italy.

Samhi Hotels Limited has informed the Exchange about 100% acquisition of Itmenaan Lodges Private Limited for an aggregate cash consideration of INR 12,00,00,000/- and a total approved investment not exceeding INR 25,00,00,000/-.

HCL Technologies Ltd has completed the acquisition of HPE's Telco Solutions business, expanding its capabilities in AI-led telecom solutions and strengthening its position in the Communications Service Providers market.

HCLTech completes acquisition of HPE's Telco Solutions business, expanding its presence in the CSP market and broadening its telecom portfolio with industry-leading IP, solutions, and integration services.

Kirloskar Pneumatic Company Ltd has completed the acquisition of 99.49% of the total voting power in Kirloskar South East Asia Co. Ltd, strengthening its strategic presence in the South-East Asian region.

Kirloskar Pneumatic Company Limited has acquired 99.49% of the total voting power in Kirloskar South East Asia Co. Limited, strengthening its strategic presence in the region.

GACM Technologies Limited has executed a Memorandum of Understanding (MOU) with Meridian Intelligence Private Limited for a cooperative and coordinated working relationship in software development, with a contract value of Rs. 1,500 lakhs.

GACM Technologies Ltd has entered into a Memorandum of Understanding (MOU) with Meridian Intelligence Private Limited, a strategic partnership aimed at achieving growth-oriented revenue generation through software development.

Park Medi World Ltd has announced the acquisition of Mehar Hospital Zirakpur, owned and operated by Mehar Mediserve LLP, and has also approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Biocon Limited has announced the commercial launch of Yesafili, a biosimilar to Regeneron's Eylea 2 mg, in the United States. The product was approved by the U.S. FDA in May 2024 and has been granted interchangeable designation, allowing substitution at the pharmacy level in accordance with state laws.

City Pulse Multiventures Ltd has acquired a 98% stake in ERECH TRADE API LLP, a limited liability partnership firm engaged in e-payment services, for ₹ 400,13,065. The acquisition is expected to add a new growth driver for the company.

City Pulse Multiventures Ltd has acquired a 98% stake in ERECH TRADE API LLP, a limited liability partnership firm engaged in e-payment services, for ₹ 400,13,065. The acquisition aims to add a new growth driver for the company both domestically and globally.

ITC Limited has completed the acquisition of the pulp and paper business of Aditya Birla Real Estate Limited, operated under the name of 'Century Pulp and Paper', along with assets, liabilities, contracts, employees, etc., as a going concern on a slump sale basis.

HCL Technologies Ltd has completed the acquisition of Telco Solutions Business from Hewlett Packard Enterprise (HPE) at 9.31 a.m. IST on August 1, 2026.

Dr. Reddy's Laboratories Ltd. has received U.S. FDA approval for its rituximab biosimilar, a biosimilar to Rituxan, for the U.S. market. The approval further strengthens Dr. Reddy's growing global biosimilars portfolio and advances its biosimilars business in the United States.

Dr. Reddy's Laboratories Ltd. has received U.S. FDA approval for its rituximab biosimilar, a biosimilar to Rituxan, for the U.S. market. The approval further strengthens Dr. Reddy's growing global biosimilars portfolio and advances its biosimilars business in the United States.